This is the authors' abstract. We don't add key points for this paper.
BackgroundMitochondrial DNA (mtDNA) is a valuable genetic bio-marker that has been implicated as a prognostic/diagnosticindicator for a number of diseases [1-3] as well as forhuman identification where forensic biologic evidencecontains too little or no nuclear DNA, such as a hair shaftwithout root or a fingernail, or where a sample from a dis-tant maternal relative is the only possibility for comparison[4-6]. Sanger sequencing has been the gold standardmethod for mtDNA typing, but the methodology has lim-itations with throughput, scalability, speed, and resolution[7]. Massively parallel sequencing technology (MPS) pro-vides platforms for more comprehensive coverage of thegenome per sample analyzed than currently is possiblewith Sanger sequencing [8,9]. Moreover, a number of dif-ferent samples, which can be distinguished by barcoding,may be sequenced simultaneously. Two of the availablepersonal genome sequencers are the Ion Torrent PersonalGenome Machine (PGM™) (LifeTechnologies, San Fran-cisco, CA) and the MiSeq
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Seo et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: